Peter Lichtlen serves as Executive at Sucampo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Peter Lichtlen has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 13, 2018 involved selling 24,000 shares valued at $432.0K.
Peter Lichtlen currently holds 24,000 shares of Sucampo Pharmaceuticals, Inc. (SCMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Lichtlen has been a net neutral trader of SCMP stock. They have purchased $0 and sold $0 worth of shares.
Peter Lichtlen's most recent insider trade was on Feb 13, 2018, when they sold 24,000 shares at $18.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |